We asked our readers to give us feedback into how much they knew about GLP-1 Analogs and a broad cross-section replied. Take a look at 5 of the questions and how your colleagues answered….
It appears that most of you knew that a large amount of GLP-1 production is lost by the time diabetes develops and that this contributes heavily to difficulties controlling glucose.
See more GLP-1 Agonist Resources.
The use of GLP-1 agonists are not currently indicated with insulin and it was interesting to see that over 50% of all nurses, nurse practitioners, and pharmacists as well as 45% of dietitians thought it was indicated with insulin. Only physicians were well versed in the indications.
Even though many more prescriptions were written for DPP-4 inhibitors than GLP-1 agonists in 2009 most of you knew that there is more A1c lowering power in GLP-1 agonists.
The use of a DPP-4 Inhibitor rather than a GLP-1 agonist is even more puzzling when you consider that most everyone knew that there cardiovascular benefits associated with GLP-1 agonists as well.
I was surprised to see that some professionals felt that GLP-1 Agonists are available orally and can only assume that some feel that DPP-4 inhibitors and GLP-1 Agonists are the same.
Click below to access other articles in this series:
GLP-1 Knowledge Survey Part II
Copyright © 2011 Diabetes In Control, Inc.